3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Rectal Neoplasms
1
Pathologic Complete Response
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Hemangiosarcoma
1
HER2-positive Breast Cancer
1
Colorectal Neoplasms
1
Anatomic Stage II Breast Cancer AJCC v8
1
Adenocarcinoma
1
Interventions
Gemcitabine
8
Cisplatin
8
durvalumab
4
Oxaliplatin
3
Irinotecan
3
Folfox protocol
3
Bevacizumab
3
zanidatamab
2
pembrolizumab
2
Fluorouracil
2
Capecitabine
2
tremelimumab
1
trastuzumab deruxtecan
1
toripalimab
1
poly ICLC
1
niraparib
1
neratinib
1
ivosidenib
1
futibatinib
1
fludarabine
1
envafolimab
1
encorafenib
1
brigimadlin
1
binimetinib
1
apatinib
1
Trastuzumab
1
Self Expandable Metallic Stents
1
Psilocybin
1
Peptides
1
Pemetrexed
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Biliary Tract Neoplasms
×
tucatinib
×
30 days
×
Clear all
No trials found.